North Dakota Healthcare Newswire: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on North Dakota Healthcare Newswire.

Press releases published on September 14, 2026

6 minutes ago

Dogwood Announces Completion of Enrollment in Ongoing Halneuron® Phase 2b Trial

Indeterminate GlobeNewswire

16 minutes ago

Moleculin to Showcase New Annamycin Data at AACR Conference on Pancreatic Cancer and Two European Scientific Meetings

Indeterminate GlobeNewswire

21 minutes ago

GATC Health Joins Critical Path Institute’s New Approach Methodologies Developer Coalition to Advance AI-Enabled Regulatory Science

Indeterminate GlobeNewswire

21 minutes ago

Tris Pharma Introduces New 30-Count Bottle Size for QuilliChew ER® (methylphenidate HCl) Extended-Release Chewable Tablets for Attention Deficit Hyperactivity Disorder (ADHD)

Indeterminate GlobeNewswire

21 minutes ago

Onconetix Provides Strategic Bridge Financing to Realbotix LLC in Support of Pending Acquisition

Indeterminate GlobeNewswire

21 minutes ago

Tenaya Therapeutics Granted U.S. FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for TN-401 for the Treatment of PKP2-Associated Arrhythmogenic Right Ventricular Cardiomyopathy

Indeterminate GlobeNewswire

21 minutes ago

Leading Independent Proxy Advisory Firm ISS Recommends Stockholders Vote “FOR” All Six of Anavex’s Highly Qualified Director Nominees

Indeterminate GlobeNewswire

21 minutes ago

Cardiff Oncology and Nerviano Medical Sciences Amend their 2017 Exclusive License Agreement

Indeterminate GlobeNewswire

42 minutes ago

Nord Fascia Launches Personalized Fascia Release and Mobility App

Indeterminate GlobeNewswire

43 minutes ago

Santa Ana Bio Announces First Subjects Dosed in Phase 1 Study of SAB01 to Treat Autoimmune Inflammatory Diseases

Indeterminate GlobeNewswire

an hour ago

Teva Begins Trading Ordinary Shares Directly on the NYSE, Marking a Milestone in its Pivot to Growth Strategy

Indeterminate GlobeNewswire

an hour ago

Radiopharm Theranostics Selected for Late-Breaking Oral Presentation of Positive Data from Interim Analysis of U.S. Phase 2b Imaging Trial of RAD101 at 2026 Society of Neuro-Oncology Annual Meeting

Indeterminate GlobeNewswire

an hour ago

Evaxion applies its AI-Immunology™ platform in autoimmune diseases

Indeterminate GlobeNewswire

an hour ago

Telomir Announces Research with The Ohio State University Demonstrating In-Vitro Anti-Cancer Activity in Human and Canine Osteosarcoma Models

Indeterminate GlobeNewswire

an hour ago

Alveus Therapeutics Initiates Phase 2 PRESERVE Trial to Evaluate ALV-100 for Chronic Weight Management

Indeterminate GlobeNewswire

an hour ago

Revelyx Bio Reports Positive Topline Phase 2 Results for YY003, a Recombinant, Ready-to-Use Liquid Botulinum Toxin Type A, in Moderate-to-Severe Glabellar Lines

Indeterminate GlobeNewswire

an hour ago

Baird Medical Highlights Participation at CIRSE 2026 and Showcases Microwave Ablation Technology

Indeterminate GlobeNewswire

an hour ago

Nasus Pharma Announces FDA Clearance to Initiate Clinical Study of NS002 in the Treatment of Anaphylaxis

Indeterminate GlobeNewswire

an hour ago

Leios Therapeutics Announces Positive End-of-Phase 2 Meeting with FDA for 10XB-101 for Moderate-to-Severe Submental Fat Fullness

Indeterminate GlobeNewswire

an hour ago

Akebia Therapeutics Announces First Patient Dosed in Phase 2 Basket Trial of Ebribafusp in Rare Complement-Mediated Kidney Diseases

Indeterminate GlobeNewswire